| Drug Name |
Sotalol |
| Drug ID |
BADD_D02060 |
| Description |
Sotalol is a methanesulfonanilide developed in 1960.[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.[L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm in atrial fibrillation or flutter.[Label,L6373,L6376] |
| Indications and Usage |
For the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (AFIB/AFL)] in patients with symptomatic AFIB/AFL who are currently in sinus rhythm. Also for the treatment of documented life-threatening ventricular arrhythmias. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
C07AA07 |
| DrugBank ID |
DB00489
|
| KEGG ID |
D08525
|
| MeSH ID |
D013015
|
| PubChem ID |
5253
|
| TTD Drug ID |
D04VMT
|
| NDC Product Code |
Not Available |
| Synonyms |
Sotalol | Sotalol Hydrochloride | Sotalol Monohydrochloride | MJ-1999 | MJ 1999 | MJ1999 | Darob |
